Absci Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.8M | $4.5M | $5.7M | $5.7M | $4.8M |
| Selling, general & administrative | $35.1M | $36.2M | $37.8M | $40.6M | $28.8M |
| Research and development | $81.4M | $63.9M | $48.1M | $58.9M | $44.6M |
| Operating expenses | $123.1M | $113.4M | $121.2M | $112.5M | $80.0M |
| Operating income | -$120.3M | -$108.9M | -$115.5M | -$106.8M | -$75.2M |
| Interest expense | $209,000 | $565,000 | $1.0M | $972,000 | $3.4M |
| Pretax income | -$115.1M | -$103.0M | -$110.5M | -$105.4M | -$109.9M |
| Income tax expense | $69,000 | $70,000 | $100,000 | -$461,000 | -$8.9M |
| Net income | -$115.2M | -$103.1M | -$110.6M | -$104.9M | -$101.0M |
| Balance Sheet | |||||
| Cash and equivalents | $20.0M | $41.2M | $72.4M | $60.0M | $252.6M |
| Current assets | $149.6M | $133.8M | $120.6M | $186.9M | $273.1M |
| Total assets | $216.3M | $213.6M | $217.3M | $321.0M | $426.2M |
| Current liabilities | $22.8M | $28.7M | $29.6M | $30.3M | $33.9M |
| Total liabilities | $26.8M | $34.5M | $41.1M | $46.6M | $60.1M |
| Total debt | — | $4.3M | $8.8M | $12.6M | $3.5M |
| Stockholders' equity | $189.4M | $179.1M | $176.2M | $274.4M | $366.1M |
| Cash Flow Statement | |||||
| Cash from operations | -$92.9M | -$72.4M | -$64.6M | -$81.3M | -$60.6M |
| Depreciation and amortization | $11.7M | $13.4M | $14.0M | $13.0M | $6.7M |
| Stock-based compensation | $18.3M | $19.5M | $11.4M | $12.5M | $10.6M |
| Capital expenditure | $1.1M | $404,000 | $860,000 | $16.2M | $38.0M |
| Free cash flow | -$94.0M | -$72.8M | -$65.5M | -$97.5M | -$98.6M |
| Impairments | — | $0 | $21.3M | $0 | — |
Shares outstanding 155.9M · Free float 74.0%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.